Omega-3 Fatty Acids for the Management of Hypertriglyceridemia

Published: August 19, 2019

Pile of capsules Omega-3 on white background
  • Hypertriglyceridemia (HTG) and very high triglycerides (VHTG) are becoming increasingly prevalent, likely driven by growing rates of obesity and diabetes mellitus.
  • This advisory informs providers about newly approved prescription omega-3 fatty acids (n-3 FA) to treat HTG and VHTG.
  • The advisory summarizes clinical evidence on effects of n-3 FA on plasma concentrations of triglycerides and other lipids and lipoproteins in individuals with elevated triglycerides.